Schizophrenia News

ORLANDO, Fla. — ALKS 3831, composed of a flexible dose of olanzapine and a 10-mg fixed dose of the opioid receptor antagonist samidorphan, showed greater antipsychotic efficacy compared with placebo in adults with acute exacerbation of schizophrenia, according to poster data presented here.

ORLANDO, Fla. — Rexulti was safe and well tolerated in patients experiencing severe psychotic symptoms at baseline, according to poster data presented at Psych Congress.

Secondary prevention cardiovascular treatment prescribed after myocardial infarction was linked to reduced mortality rates among patients with schizophrenia, study findings showed.

Minocycline failed to reduce negative or other symptoms of schizophrenia in patients with first-episode psychosis, according to data published in The Lancet Psychiatry.

Although the link between frequent and problem cannabis use and psychotic-like experiences primarily involves genetic overlap, individual-specific pathways appear to also play a role, according to an analysis published in JAMA Psychiatry.

Living in urban areas may not always be associated with a higher rate of psychotic disorders, according to a viewpoint published in JAMA Psychiatry.

After mapping interindividual differences in brain structure, researchers found only a few brain loci had the same abnormalities in more than 2% of patients with the same schizophrenia spectrum disorder.

A position paper issued by the European Psychiatric Association supported exercise as a core additional treatment for severe mental illness.

Findings from a longitudinal, functional MRI study indicated that young patients with recent-onset schizophrenia exhibited developmental trends in behavioral performance and brain function throughout adolescence and early adulthood similar to age-matched healthy controls.

Electroencephalography, or EEG, technology that measures brain function could encourage earlier diagnoses of common mental and neurological disorders, including autism, ADHD and dementia, according to findings published in The Neurodiagnostic Journal.